
- Pharmaceutical Technology-01-02-2016
- Volume 40
- Issue 1
Ultra High-Performance Liquid Chromatograph System
The Prominence-i LC-2030 LT is a new model of Shimadzu’s i-Series integrated high-performance liquid chromatograph and ultra high-performance liquid chromatograph systems.
The Prominence-i LC-2030 LT is a new model of Shimadzu’s i-Series integrated high-performance liquid chromatograph and ultra high-performance liquid chromatograph systems. The new system comes without a PDA and UV detector, allowing users to select a detector of their choice. The system provides a 14-second injection cycle time and 1536 continuous, unattended analyses using 4 x 384 well micro plates. The new model contains a color touch panel that supports control of the analysis, monitoring instrument status, and usage of the system and consumables. The panel also assists with maintenance and displays a chromatogram. The system contains auto-startup, auto system suitability test, quick-batch function, auto-shutdown, and auto-validation for system qualification. Instrument power can be turned off upon shutdown, saving more than 95% of standby electricity. Solvent and sample consumption can also be reduced to one-fifth of the usual amount without sacrificing data quality.
Articles in this issue
almost 10 years ago
Parenteral Packaging: 2021almost 10 years ago
Politics and Pricing Will Challenge Manufacturers in 2016almost 10 years ago
Managing Market Expansion’s Effect on Proceduresalmost 10 years ago
Phase-Appropriate Formulation and Process Designalmost 10 years ago
Reducing the Documentation Burden in Process Validationalmost 10 years ago
Reducing the Environmental Impact of Manufacturingalmost 10 years ago
Cleaning Limits—Why the 10-ppm Criterion should be Abandonedalmost 10 years ago
Using Deterministic Container Closure Integrity Testingalmost 10 years ago
The Market Consolidates for Better Servicealmost 10 years ago
Global Drug DirectionsNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.



